Microbot Medical logo

Microbot MedicalNASDAQ: MBOT

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 March 1992

Next earnings report:

15 May 2025

Last dividends:

N/A

Next dividends:

N/A
$16.00 M
-74%vs. 3y high
22%vs. sector
-vs. 3y high
-vs. sector
-46%vs. 3y high
76%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Wed, 20 Nov 2024 21:43:25 GMT
$0.94-$0.02(-2.48%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

MBOT Latest News

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
globenewswire.com30 September 2024 Sentiment: POSITIVE

Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study BRAINTREE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it is currently experiencing an acceleration of patient enrollment for ACCESS-PVI human clinical trial for LIBERTY®.

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
globenewswire.com17 September 2024 Sentiment: POSITIVE

Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024

Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY
zacks.com23 August 2024 Sentiment: POSITIVE

Microbot Medical (MBOT) signs a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using LIBERTY.

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
globenewswire.com22 August 2024 Sentiment: POSITIVE

The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform

Microbot Medical (MBOT) Gets Quality Certification for its System
zacks.com19 August 2024 Sentiment: POSITIVE

Microbot Medical (MBOT) secures ISO 13485:2016 certification for its LIBERTY Endovascular Robotic System, a milestone that streamlines European and FDA regulatory compliance for future commercialization.

Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics
zacks.com05 August 2024 Sentiment: POSITIVE

Microbot Medical (MBOT) announces an agreement with Emory University to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system.

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
globenewswire.com01 August 2024 Sentiment: POSITIVE

The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
globenewswire.com18 July 2024 Sentiment: POSITIVE

As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women's Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women's Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial

Microbot Medical (MBOT) Progresses in Its Human Clinical Trial
zacks.com11 July 2024 Sentiment: POSITIVE

Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY system.

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
globenewswire.com09 July 2024 Sentiment: POSITIVE

Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company's Pivotal Human Clinical Trial.

What type of business is Microbot Medical?

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

What sector is Microbot Medical in?

Microbot Medical is in the Healthcare sector

What industry is Microbot Medical in?

Microbot Medical is in the Medical Instruments & Supplies industry

What country is Microbot Medical from?

Microbot Medical is headquartered in United States

When did Microbot Medical go public?

Microbot Medical initial public offering (IPO) was on 25 March 1992

What is Microbot Medical website?

https://microbotmedical.com

Is Microbot Medical in the S&P 500?

No, Microbot Medical is not included in the S&P 500 index

Is Microbot Medical in the NASDAQ 100?

No, Microbot Medical is not included in the NASDAQ 100 index

Is Microbot Medical in the Dow Jones?

No, Microbot Medical is not included in the Dow Jones index

When was Microbot Medical the previous earnings report?

No data

When does Microbot Medical earnings report?

The next expected earnings date for Microbot Medical is 15 May 2025